Sahlgren C - Search Results

1

Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.

Baghirov H, Karaman D, Viitala T, Duchanoy A, Lou YR, Mamaeva V, Pryazhnikov E, Khiroug L, de Lange Davies C, Sahlgren C, Rosenholm JM. Baghirov H, et al. Among authors: sahlgren c. PLoS One. 2016 Aug 22;11(8):e0160705. doi: 10.1371/journal.pone.0160705. eCollection 2016. PLoS One. 2016. PMID: 27547955 Free PMC article.

2

Targeting of porous hybrid silica nanoparticles to cancer cells.

Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: sahlgren c. ACS Nano. 2009 Jan 27;3(1):197-206. doi: 10.1021/nn800781r. ACS Nano. 2009. PMID: 19206267

3

Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.

Rosenholm JM, Peuhu E, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: sahlgren c. Nano Lett. 2009 Sep;9(9):3308-11. doi: 10.1021/nl901589y. Nano Lett. 2009. PMID: 19736973

4

Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.

Rosenholm JM, Peuhu E, Bate-Eya LT, Eriksson JE, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: sahlgren c. Small. 2010 Jun 6;6(11):1234-41. doi: 10.1002/smll.200902355. Small. 2010. PMID: 20486218

5

Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.

Rosenholm JM, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: sahlgren c. Nanoscale. 2010 Oct;2(10):1870-83. doi: 10.1039/c0nr00156b. Epub 2010 Aug 23. Nanoscale. 2010. PMID: 20730166 Review.

6

Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment.

Rosenholm JM, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: sahlgren c. Curr Drug Targets. 2011 Jul 1;12(8):1166-86. doi: 10.2174/138945011795906624. Curr Drug Targets. 2011. PMID: 21443474 Review.

7

Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer.

Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, Fortelius LE, Landor S, Toivola DM, Lindén M, Sahlgren C. Mamaeva V, et al. Among authors: sahlgren c. Mol Ther. 2011 Aug;19(8):1538-46. doi: 10.1038/mt.2011.105. Epub 2011 May 31. Mol Ther. 2011. PMID: 21629222 Free PMC article.

8

Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms.

Landor SK, Mutvei AP, Mamaeva V, Jin S, Busk M, Borra R, Grönroos TJ, Kronqvist P, Lendahl U, Sahlgren CM. Landor SK, et al. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18814-9. doi: 10.1073/pnas.1104943108. Epub 2011 Nov 7. Proc Natl Acad Sci U S A. 2011. PMID: 22065781 Free PMC article.

9

Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.

Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M. Rosenholm JM, et al. Among authors: sahlgren c. Nanomedicine (Lond). 2012 Jan;7(1):111-20. doi: 10.2217/nnm.11.166. Nanomedicine (Lond). 2012. PMID: 22191780 Review.

10

Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization.

Karaman DS, Desai D, Senthilkumar R, Johansson EM, Råtts N, Odén M, Eriksson JE, Sahlgren C, Toivola DM, Rosenholm JM. Karaman DS, et al. Among authors: sahlgren c. Nanoscale Res Lett. 2012 Jul 1;7(1):358. doi: 10.1186/1556-276X-7-358. Nanoscale Res Lett. 2012. PMID: 22747910 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters